230 related articles for article (PubMed ID: 26448102)
21. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.
Begley M; Cotter PD; Hill C; Ross RP
Appl Environ Microbiol; 2009 Sep; 75(17):5451-60. PubMed ID: 19561184
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial peptides "bacteriocins": an overview of their diverse characteristics and applications.
Nishie M; Nagao J; Sonomoto K
Biocontrol Sci; 2012 Mar; 17(1):1-16. PubMed ID: 22451427
[TBL] [Abstract][Full Text] [Related]
24.
Ye J; Fugaban JII; Dioso CM; Vazquez Bucheli JE; Choi GH; Kim B; Holzapfel WH; Todorov SD
Foodborne Pathog Dis; 2023 Jul; 20(7):279-293. PubMed ID: 37366658
[TBL] [Abstract][Full Text] [Related]
25. A novel thermotolerant and acidotolerant peptide produced by a Bacillus strain newly isolated from a fermented food (kimchi) shows activity against multidrug-resistant bacteria.
Choi YH; Cho SS; Simkhada JR; Yoo JC
Int J Antimicrob Agents; 2012 Jul; 40(1):80-3. PubMed ID: 22578764
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial activity and genotypic-phenotypic characteristics of bacteriocin-producing Bacillus subtilis KKU213: potential as a probiotic strain.
Khochamit N; Siripornadulsil S; Sukon P; Siripornadulsil W
Microbiol Res; 2015 Jan; 170():36-50. PubMed ID: 25440998
[TBL] [Abstract][Full Text] [Related]
27. Identification and classification of known and putative antimicrobial compounds produced by a wide variety of Bacillales species.
Zhao X; Kuipers OP
BMC Genomics; 2016 Nov; 17(1):882. PubMed ID: 27821051
[TBL] [Abstract][Full Text] [Related]
28. Bacillusin A, an Antibacterial Macrodiolide from Bacillus amyloliquefaciens AP183.
Ravu RR; Jacob MR; Chen X; Wang M; Nasrin S; Kloepper JW; Liles MR; Mead DA; Khan IA; Li XC
J Nat Prod; 2015 Apr; 78(4):924-8. PubMed ID: 25756620
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial peptides of the genus Bacillus: a new era for antibiotics.
Sumi CD; Yang BW; Yeo IC; Hahm YT
Can J Microbiol; 2015 Feb; 61(2):93-103. PubMed ID: 25629960
[TBL] [Abstract][Full Text] [Related]
30. Lactic acid bacteria and their bacteriocins: new potential weapons in the fight against methicillin-resistant
Yaacob SN; Wahab RA; Misson M; Sabullah MK; Huyop F; Zin NM
Future Microbiol; 2022 Jun; 17():683-699. PubMed ID: 35414206
[TBL] [Abstract][Full Text] [Related]
31. Structure and biosynthetic assembly of gulmirecins, macrolide antibiotics from the predatory bacterium Pyxidicoccus fallax.
Schieferdecker S; König S; Weigel C; Dahse HM; Werz O; Nett M
Chemistry; 2014 Nov; 20(48):15933-40. PubMed ID: 25287056
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
Lawton EM; Cotter PD; Hill C; Ross RP
FEMS Microbiol Lett; 2007 Feb; 267(1):64-71. PubMed ID: 17233677
[TBL] [Abstract][Full Text] [Related]
33. The Bacillus cereus group is an excellent reservoir of novel lanthipeptides.
Xin B; Zheng J; Xu Z; Song X; Ruan L; Peng D; Sun M
Appl Environ Microbiol; 2015 Mar; 81(5):1765-74. PubMed ID: 25548056
[TBL] [Abstract][Full Text] [Related]
34. Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.
Maffioli SI; Monciardini P; Catacchio B; Mazzetti C; Münch D; Brunati C; Sahl HG; Donadio S
ACS Chem Biol; 2015 Apr; 10(4):1034-42. PubMed ID: 25574687
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Mar; 19(5):1292-5. PubMed ID: 19208475
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
[TBL] [Abstract][Full Text] [Related]
37. Structural Characterization and Bioactivity Analysis of the Two-Component Lantibiotic Flv System from a Ruminant Bacterium.
Zhao X; van der Donk WA
Cell Chem Biol; 2016 Feb; 23(2):246-256. PubMed ID: 27028884
[TBL] [Abstract][Full Text] [Related]
38. Two-peptide lantibiotics: a medical perspective.
Lawton EM; Ross RP; Hill C; Cotter PD
Mini Rev Med Chem; 2007 Dec; 7(12):1236-47. PubMed ID: 18220976
[TBL] [Abstract][Full Text] [Related]
39. A review on characterization, applications and structure-activity relationships of Bacillus species-produced bacteriocins.
Basi-Chipalu S; Sthapit P; Dhital S
Drug Discov Ther; 2022 May; 16(2):55-62. PubMed ID: 35466124
[TBL] [Abstract][Full Text] [Related]
40. Identification of Putative Novel Class-I Lanthipeptides in Firmicutes: A Combinatorial
Alkhalili RN; Canbäck B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
